Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals

1. A method of reducing risk of periparturient hypocalcemia in at least one periparturient ruminant animal, the method comprising the steps of:

a) measuring a blood phosphorus (P) concentration in the at least one periparturient ruminant animal; and

b) after step a) perorally administering to the periparturient ruminant animal during at least part of a prepartum period of the periparturient ruminant animal a composition comprising:

i. an effective amount of a phosphorus-binding compound to control the blood phosphorus concentration in a range of 1.5-3.5 mg P per dL of blood in the periparturient ruminant animal, wherein the phosphorus-binding compound comprises an aluminum compound; and

ii. a pharmacologically acceptable carrier.

2. The method of claim 1 , wherein the blood phosphorus concentration of step b) is controlled to be in a range of 1.8-3.0 mg P per dL of blood.

3. The method of claim 1 , wherein the blood phosphorus concentration of step b) is controlled to be in a range of 2.0-2.5 mg P per dL of blood.

4. The method of claim 1 , wherein:

if the blood phosphorus concentration is below the range, administration rate of the composition of step b) is decreased or the composition is reformulated to decrease the amount of the compound and/or increase the phosphorus to aluminum ratio; and,

if the blood phosphorus concentration is above the range, administration rate of the composition of step b) is increased or the composition is reformulated to increase the amount of the compound relative to phosphorus in the composition and/or decrease the phosphorus to aluminum ratio,

so that the blood phosphorus concentration is brought into the range.

5. The method of claim 1 , wherein the measuring of step a) is done periodically.

6. The method of claim 1 , wherein the phosphorus-binding compound of step b) reduces bioavailability of the phosphorus in a digestive system of the periparturient ruminant animal.

7. The method of claim 1 , wherein the periparturient ruminant animal is a dairy cow.

8. The method of claim 1 , wherein the composition of step b) is a feed composition, and the pharmacologically acceptable carrier comprises one or more animal feed components other than the phosphorus-binding compound.

9. The method of claim 1 , wherein:

a) the composition is a feed composition;

b) the pharmacologically acceptable carrier comprises one or more animal feed components other than the phosphorus-binding compound; and

c) the feed composition provides a dietary phosphorus (P) to aluminum (Al) weight ratio in a range of 0.7:1 to 1.4:1.

10. The method of claim 9 , wherein the weight ratio is in a range of 0.8:1 to 1.1:1.

11. The method of claim 1 , wherein the aluminum compound comprises an aluminosilicate, aluminum sulfate, aluminum chloride, aluminum ammonium sulfate, aluminum potassium sulfate, aluminum sodium sulfate, aluminum calcium silicate, aluminum hydroxide, aluminum bromide, aluminum iodide, aluminum nitrate, aluminum carbonate, a hydrate thereof or any mixture thereof.

12. The method of claim 1 , wherein the aluminum compound comprises aluminum sulfate, aluminum chloride, aluminum hydroxide, a hydrate thereof or any mixture thereof.

13. A method of inducing a transient phase hypophosphatemia in a periparturient ruminant animal, the method comprising the steps of:

a) measuring a blood phosphorus (P) concentration in the at least one periparturient ruminant animal; and

b) after step a) perorally administering to the periparturient ruminant animal during at least part of a prepartum period of the periparturient ruminant animal a composition comprising:

i. an effective amount of a phosphorus-binding compound to control the blood phosphorus concentration in the periparturient ruminant animal in a range of 1.5-3.5 mg P per dL of blood, wherein the phosphorus binding compound comprises an aluminum compound; and

ii. a pharmacologically acceptable carrier.